Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
MEK
53 Products
53 Products
322 Diseases
16065 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
31
62
93
124
155
186
217
248
279
310
Mekinist
(trametinib) / Novartis, BeiGene
Koselugo
(selumetinib) / Merck (MSD), AstraZeneca
Mektovi
(binimetinib) / Ono Pharma, Pierre Fabre, Pfizer
Cotellic
(cobimetinib) / Exelixis, Roche
Zepsun
(donafenib) / Suzhou Zelgen
avutometinib
(VS-6766) / Verastem
mirdametinib
(PD-0325901) / SpringWorks Therap, BeiGene
pimasertib
(AS703026) / Day One Biopharma
refametinib
(BAY86-9766) / Bayer
tunlametinib
(HL-085) / Tianjin Binjiang Pharma
Hocena
(antroquinonol) / Golden Biotechnology
FCN-159
/ Fosun Pharma
E6201
/ Strategia Therap
REC-4881
/ Recursion Pharma
SHR7390
/ Jiangsu Hengrui Pharma
LNP3794
/ Boehringer Ingelheim
NFX-179
/ NFlection Therap
zapnometinib
(ATR-002) / Atriva Therap
CI-1040
/ Pfizer
CS3006
/ CStone Pharma
GDC-0623
/ Roche
TQ-B3234
/ Sino Biopharm
WX-554
/ Heidelberg Pharma
ABM-168
/ ABM Therap
ARRY-300
/ Novartis
AZD8330
/ AstraZeneca, Pfizer
BI 847325
/ Boehringer Ingelheim
CH4987655
/ Roche
IK-595
/ Ikena Oncology
IMM-1-104
/ Immuneering
IMM-6-415
/ Immuneering
MG-D-1509
/ Metagone Biotech
MSC2015103B
/ Day One Biopharma
PAS-004
/ Pasithea
PF-07799544
/ Pfizer
trametinib repurposed
(SNR1611) / GENUV